Introduction: Nutrition and physical activity are two major issues in the management of CKD patients who are often older, have comorbidities, and are prone to malnutrition and physical inactivity, conditions that cause loss of quality of life and increase the risk of death. We performed a multidimensional assessment of nutritional status and of physical performance and activity in CKD patients on conservative therapy in order to assess the prevalence of sedentary behavior and its relationship with body composition. Methods: A total of 115 consecutive stable CKD patients aged 45–80 years were included in the study. They had no major skeletal, muscular, or neurological disabilities. All patients underwent a multidimensional assessment of body composition, physical activity, and exercise capacity. Results: Sedentary patients, as defined by mean daily METs <1.5, were older and differed from non-sedentary patients in terms of body composition, exercise capacity, and nutrient intake, even after adjusting for age. Average daily METs were positively associated with lean body mass, muscle strength, 6MWT performance but negatively associated with fat body mass, body mass index, and waist circumference. In addition, a sedentary lifestyle may have negative effects on free fat mass, muscle strength, and exercise capacity and may increase fat body mass. Conversely, decrease in muscle mass and/or an increase in fat mass may lead to a decrease in physical activity and exercise capacity. Conclusion: There is a clear association and potential interrelationship between nutritional aspects and exercise capacity in older adults with CKD: they are really the two sides of the same coin.

Worldwide, one in four adults does not engage in WHO recommended physical activity, and most of the elderly people with disabilities or chronic diseases have even fewer opportunities to be physically active. In addition, changes in transport models, increased urbanization, and technologies have led to an increase in physical inactivity levels to as high as 70% in many countries.

The “Global Action Plan on Physical Activity 2018–2030” approved by the WHO defines four strategic goals – active society, active environments, active people, and active systems – to be implemented in all countries in order to reduce the global prevalence of physical inactivity by at least 15% by 2030. The WHO action plan emphasizes the need for a systemic approach that addresses all factors that can influence physical activity: social, economic, cultural, environmental, educational [1, 2].

Physical activity has been widely shown to improve physical and mental health [3]. It is an essential tool in the prevention and treatment of obesity, diabetes and insulin resistance, cardiovascular disease and to counteract sarcopenia, which is increasing in western societies due to demographic changes.

It is also important to stress the difference between “sedentary lifestyle” and inactivity: people who meet the minimum recommended daily amount of PA can still be considered sedentary if they spend the rest of the day sitting. The effects of sedentary time are independent of physical activity levels and can be negative even in people who meet the minimum recommended level of physical activity. Sedentary activities are those characterized by an energy expenditure (EE) of less than 1.5 METs.

Chronic kidney disease (CKD) is a common disease in developed countries, affecting 10–15% of the population, with a prevalence increasing with age: CKD affects about 30% and even more people over the age of 60. CKD is often associated with comorbidities, high cardiovascular risk and a prevalence of frailty, functional impairment and mobility limitations, body composition abnormalities, and poor nutritional status. In this setting, low physical activity and exercise capacity contribute to poor quality of life and increased risk of protein-energy wasting, morbidity, and mortality [4]. In this single-center study, we performed a multidimensional assessment of nutritional status and of physical performance and activity in CKD patients on conservative therapy to assess the prevalence of sedentary behavior and the relationship with body composition.

This is a cross-sectional study on 115 stable consecutive patients (96 males, 19 females) aged 45–80 years, affected by stage 3–5 NDCKD. Patients had no major skeletal, muscular, or neurological disabilities, or had not reported severe limitation in walking.

Patients were excluded if they had severe heart failure (NYHA class IV), respiratory insufficiency, cancer, dementia, psychiatric or neurologic diseases, inflammatory systemic diseases, Barthel Index and/or Karnowsky score <100, had been hospitalized in the previous 3 months, or refused to participate in the study. All patients received standard care including dietary support, according to their clinic and residual kidney function: 69.8% followed a 1.0–0.8 g/kg/day protein diet [5]; 30.3% followed a low protein diet (19.4% an animal-based low protein diet, 10.8% a plant-based low protein diet) [6‒8]. All patients underwent a nutritional and functional assessment including anthropometry, body composition analysis (single-frequency bioimpedance analysis), dietary recall, biochemistry, physical activity, and functional testing, as described below.

Nutritional Status Assessment

Body weight was assessed on a mechanical scale with the patient wearing light clothes and no shoes. Height was measured with a stadiometer. Body mass index (BMI) was calculated as body weight (kg)/height2 (m2). Other measures included waist and hip circumferences, nondominant middle arm circumference (MAC), and triceps skinfold thickness (TST). TST and MAC were used to calculate the middle-arm muscle circumference and the middle-arm muscular area using specific formulas:

Body composition analysis was conducted using a bioelectrical impedance single-frequency analyzer (BIA/STA, Akern, Florence, Italy) with a distal, tetrapolar technique, delivering an excitation current at 50 kHz. Impedance (Z) represents the force that interferes with the flow of electric current and is given by the vectorial sum of the resistance (Rz) and the reactance (Xc): the two bioelectric parameters given by the body analyzer. The phase angle is the most immediate bioelectric index that is derived from a proportion between resistance and reactance according to this formula: phaseangle=ArctangXc/Rz×180×π.

It reflects hydration status and soft tissue cellular mass. Reduced phase angle value reflects increased extra- to intracellular water ratio as well as reduced body cell mass (BCM). BCM is derived from bioimpedance analysis and body cell mass index is consequently calculated. The phase angle is considered the best predictor of survival in CKD in conservative therapy, end-stage kidney disease on peritoneal dialysis and on maintenance hemodialysis, HIV, cancer patients, and other diseases [9‒14].

Physical Activity and Performance Assessment

The level of spontaneous physical activity was assessed by SenseWear Armband (SWA, BodyMedia, Pittsburgh, PA, USA). Patients were advised to wear the device on the upper nondominant arm, in the middle tract between acromion and olecranon processes, over the triceps muscle. They were instructed to continue with their usual daily life while wearing the device and to remove only if they shower or for water activities.

The SWA device collects physiologic data through multiple sensors, particularly a two-axis accelerometer, a heat flux sensor, a skin temperature sensor, a near-body ambient temperature sensor, and a galvanic skin response sensor, that is downloaded and analyzed using a specific software (InnerView™ Research Software, version 6.1). The integrated detections from the biaxial accelerometer and the heat-related sensors have shown to provide additional information that cannot be obtained from movement sensors alone and they have high sensitivity in detecting even little changes in EE associated with complex activities. The SWA reports actual wear time. These features provide several advantages over traditional uniaxial accelerometers for assessing physical activity.

The SWA has been validated both under laboratory conditions and under free living conditions, and it has potential advantages in accuracy when compared with traditional accelerometry-based monitors [15‒18]. The validity of total EE estimates from the SWA has been supported in studies using both indirect calorimetry and doubly labelled water [19].

The metabolic equivalent task (MET) is a method for quantifying the intensity of a physical activity and the associated EE, and it is defined as the ratio of metabolic rate during a specific physical activity to a reference metabolic rate, set by convention at 3.5 mL O2 × kg−1 × min−1. Metabolic equivalent can be converted into kilocalories using the following equation: MET=Kcal/h/Kgbw; 1 MET is the energy expended at rest. So, two METs indicate that the energy expended is twice than that at rest and so on.

For example, reading, listing music correspond approximately to 1.0–1.5 METs, walking slowly corresponds to 1.5–2 METs; walking at 3 km/h or cycling at 8 km/h correspond to 2–3 METs; playing volleyball, cycling at 10 km/h correspond to 3–4 METs; walking at 6 km/h, cycling at 16 km/h, or digging correspond approximately to 5–6 METs. The measurements were carried out on a period of 3 days and include average daily METs, number of steps, the minutes spent in physical activity with intensity >3 METs/min, between 6 and 9 METs/min, or >9 METs/min. Average daily METs values may be considered as a measure of the average daily activity level; in older adults, a daily average value <1.5 METs defines a sedentary patient, 1.5–3 METs define a light activity, ≥3 METs define a moderate to vigorous activity [20].

As measured of performance, we used the 30-s sit-to-stand chair test (STS30″), 5 times sit to stand (STS5), the 6-min walking test (6MWT), and the handgrip strength test. The STS30″ is a validated test, which allows us to assess lower extremity strength in adults [21, 22]. The participant is seated in a chair with the arms crossed on the chest and hands resting against their shoulders. The score corresponds to the number of times the person can stand up from a sitting position in 30″ without the help of their arms. The STS5 takes place with the same modalities as the STS30″, but the instruction for the patient is to stand up and sit down 5 times as quickly as he/she can [23].

The 6MWT was performed according to the American Thoracic Society’s guidelines [24]. The test measures the distance a subject can walk over 6 min on a hard, flat surface. After resting for 10 min, the subject walks along a path with marked turning points. The patient is allowed to self-pace and rest as needed [24].

The handgrip strength test was performed using an analog hand dynamometer (Jamar, Duluth, MN, USA). The handle of the dynamometer was adjusted to allow a good grip. The person was told to place the arm at the side, away from the body with the elbow bent at a ninety-degree angle. The test was administered on both hands. An emphasis on “squeeze as hard as you can” was used for maximum effect. We allowed three trials with each hand, right and left hand alternately, with a pause of 10–20 s between each trial to avoid excessive fatigue.

Biochemical Data

Biochemical tests included serum creatinine, blood urea nitrogen (BUN), phosphorus, calcium, albumin, bicarbonate, parathyroid hormone (PTH), hemoglobin, and hematocrit. Tests were performed using standard laboratory methods. Estimated glomerular filtration rate (eGFR) was calculated using the CKD-EPI formula [25]. Urinary sodium, phosphate, and urea were measured on 24 h urine samples. Protein catabolic rate (PCR) was calculated by the Maroni-Mitch formula to estimate dietary protein intake [26].

Statistical Analysis

Categorical data were described by absolute and relative frequency, continuous data by mean with standard deviation and median with interquartile range, as appropriate. To verify the normality of data, Shapiro-Wilk test was applied, as appropriate. Correlation between physical activity level and continuous variables was assessed using Pearson or Spearman correlation analysis depending on whether data were normally distributed or not. Finally, all variables resulted significant in the latter univariate analysis were analyzed together by linear regression model adjusting also for age. Comparison between sedentary lifestyle subjects and not sedentary ones was tested by t test for independent sample (two tailed) or Wilcoxon signed-rank test. Significance was fixed at 0.05. All analyses were carried out by SPSS v.26 technology.

The 46.5% of patients had one comorbidity, the 26.4% two comorbidities, and the 18.6% three or more comorbidities. The 88.4% of patients had hypertension, 29.7% had diabetes, 22.5% had history of ischemic heart disease or heart failure, and 6.5% had a stroke.

Physical Activity and Performance Assessment

Daily average METs value was 1.28 ± 0.23 and the average number of steps per day was 6,618 ± 3,636. There were no significant gender differences in METs, number of steps, time spent on activities >3 METs or >6 METs.

In the performance tests, handgrip strength was lower than the expected for age and sex in 46% of patients [27]. The performance on the 6MWT, in terms of metres walked, was significantly lower than expected for age in all patients.

In the STS5, 56% of patients reported a score lower than expected for age [28]. The performance on the STS30″ was lower than expected for age and sex in 86% of subjects [22].

The level of physical activity correlated with age, as expected, and with the presence or absence of diabetes, but not with gender or type of diet (Table 1). Physical activity level was negatively correlated with age, BMI, waist and hip circumferences, ECW and percent fat mass (FM), Charlson Index, and STS5 performance. There was a positive correlation of PA level with phase angle, BCM and free fat mass (FFM) percentages, normalized estimated PCR, 6MWT and STS30″ performance.

Table 1.

Correlation between physical activity level, measured as average daily METs, and anthropometry, body composition, biochemical and functional parameters

r95% CIp value
Charlson Index −0.3788 −0.5360 to −0.1963 <0.0001 
Age, years −0.4227 −0.5660 to −0.2546 <0.0001 
Body weight, kg −0.2655 −0.4322 to −0.08112 0.0041 
BMI, kg/m2 −0.4429 −0.5827 to −0.2776 <0.0001 
Waist circumference, cm −0.4058 −0.5526 to −0.2346 <0.0001 
Hip circumference, cm −0.4035 −0.5507 to −0.2320 <0.0001 
Arm circumference, cm −0.2114 −0.3852 to −0.02314 0.0239 
Phase angle, ° 0.3808 0.1985 to 0.5376 <0.0001 
BCM, % 0.3776 0.1950 to 0.5350 <0.0001 
TBW, % 0.3423 0.1556 to 0.5054 0.0004 
ECW, % −0.3802 −0.5371 to −0.1978 <0.0001 
ICW, % 0.4474 0.2215 to 0.6278 0.0002 
FM,% −0.4966 −0.6319 to −0.3320 <0.0001 
FFM,% 0.4968 0.3321 to 0.6320 <0.0001 
MM, % 0.5127 0.1829 to 0.7387 0.0032 
BCMI, kg/m2 0.2613 0.06759 to 0.4360 0.0071 
sGlucose, mg/dL −0.3143 −0.5001 to −0.1007 0.0036 
nPCR, g/kg bw/day 0.3687 0.1299 to 0.5671 0.0025 
uPhosphate, mg/day 0.2693 0.008797 to 0.4955 0.0375 
Barthel Index 0.2431 0.05561 to 0.4140 0.0095 
Handgrip strength, kg 0.1933 0.002486 to 0.3705 0.0411 
6MWT, m 0.5552 0.4045 to 0.6766 <0.0001 
STS5 rep, s −0.3481 −0.5074 to −0.1657 0.0002 
STS30″ rep, n 0.4308 0.2589 to 0.5763 <0.0001 
r95% CIp value
Charlson Index −0.3788 −0.5360 to −0.1963 <0.0001 
Age, years −0.4227 −0.5660 to −0.2546 <0.0001 
Body weight, kg −0.2655 −0.4322 to −0.08112 0.0041 
BMI, kg/m2 −0.4429 −0.5827 to −0.2776 <0.0001 
Waist circumference, cm −0.4058 −0.5526 to −0.2346 <0.0001 
Hip circumference, cm −0.4035 −0.5507 to −0.2320 <0.0001 
Arm circumference, cm −0.2114 −0.3852 to −0.02314 0.0239 
Phase angle, ° 0.3808 0.1985 to 0.5376 <0.0001 
BCM, % 0.3776 0.1950 to 0.5350 <0.0001 
TBW, % 0.3423 0.1556 to 0.5054 0.0004 
ECW, % −0.3802 −0.5371 to −0.1978 <0.0001 
ICW, % 0.4474 0.2215 to 0.6278 0.0002 
FM,% −0.4966 −0.6319 to −0.3320 <0.0001 
FFM,% 0.4968 0.3321 to 0.6320 <0.0001 
MM, % 0.5127 0.1829 to 0.7387 0.0032 
BCMI, kg/m2 0.2613 0.06759 to 0.4360 0.0071 
sGlucose, mg/dL −0.3143 −0.5001 to −0.1007 0.0036 
nPCR, g/kg bw/day 0.3687 0.1299 to 0.5671 0.0025 
uPhosphate, mg/day 0.2693 0.008797 to 0.4955 0.0375 
Barthel Index 0.2431 0.05561 to 0.4140 0.0095 
Handgrip strength, kg 0.1933 0.002486 to 0.3705 0.0411 
6MWT, m 0.5552 0.4045 to 0.6766 <0.0001 
STS5 rep, s −0.3481 −0.5074 to −0.1657 0.0002 
STS30″ rep, n 0.4308 0.2589 to 0.5763 <0.0001 

Data show only statistically significant results.

MAMC, middle-arm muscle circumference; MAMA, middle-arm muscle area; BCM, body cell mass; TBW, total body water; ECW, extracellular water; ICW, intracellular water; FM, fat mass; FFM, free fat mass; BCMI, body cell mass index; PCR, protein catabolic rate; nPCR, normalized protein catabolic rate; 6MWT, 6-min walking test; STS, sit to stand; MET, metabolic equivalent task; REE, resting energy expenditure; EE, energy expenditure; nEE, normalized energy expenditure.

Multivariate statistical analysis was performed to analyze the effect of several independent variables, namely, age, BMI, handgrip strength, body composition parameter as percentage of FM and fat-free mass, and normalized PCR on physical activity level based on METs score. There was an independent significant association between physical activity level and age (β = −0.01107, 95% CI: −0.01689 to −0.005252, p = 0.0004) and between physical activity level and BMI (β = −0.06023, 95% CI: −0.1113 to −0.009118, p = 0.0219).

Subjects were classified as having a sedentary or not sedentary lifestyle based on average daily METs value, using 1.5 as the cut-off value [20]. Table 2 shows the main differences between the two groups.

Table 2.

Main features of the studied subjects based on their sedentary or not sedentary lifestyle

Sedentary lifestyle (n = 95)Not sedentary lifestyle (n = 20)p value
Age, years 72.0 (67.0, 77.0) 65.5 (51.8, 71.8) 0.0002 
BMI, kg/m2 28.2 (25.9, 30.9) 26.3 (23.8, 28.4) 0.0077 
Waist circumference, cm 103±10.2 96.9±9.4 0.0192 
Hip circumference, cm 105±7.9 101±5.2 0.0151 
Arm circumference, cm 30.2±2.8 28.9±2.6 0.0710 
Triceps skinfold, cm 1.2 (0.9, 1.5) 1.2 (0.73, 1.85) 0.8990 
MAMC, cm 26.1±2.8 24.7±3.1 0.0522 
MAMA, cm2 54.2±13.1 49.1±11.7 0.1190 
Phase angle, ° 4.7 (4.1, 5.4) 5.2 (4.9, 6.1) 0.0051 
BCM, % 46.8±5.9 51.3±4.4 0.0039 
TBW, % 52.9±5.1 55.9±5.0 0.0298 
ECW, % 52.2±5.6 48.0±4.1 0.0037 
ICW, % 47.9±6.0 54.0±4.5 0.0055 
FM, % 30.8±7.0 24.7±6.9 0.0013 
FFM, % 69.2±7.0 75.3±6.9 0.0013 
BCMI, kg/m2 9.2±1.6 10.2±1.3 0.0263 
eGFR, mL/min/1.73 m2 31.4±12.8 30.6±13.2 0.8016 
sSodium, mEq/L 141±2.5 141±2.4 0.7913 
sPotassium, mEq/L 4.7±0.5 4.8±0.6 0.4055 
sCalcium, mg/dL 9.3±0.5 9.4±0.4 0.5603 
sPhosphate, mg/dL 3.3±0.6 3.3±0.8 0.9333 
sBicarbonate, mEq/L 24.5±2.9 23.8±2.6 0.4307 
sGlucose, mg/dL 99.0 (87.0, 114) 87 (82, 102) 0.2650 
HbA1c, % 6.3 (5.9, 7.0) 6.4 (6.2, 7.0) 0.6830 
sUric acid, mg/dL 6.4±1.6 5.5±1.0 0.0258 
sCholesterol, mg/dL 177±35.3 185±29.1 0.4463 
HDL cholesterol, mg/dL 47.5 (39.0, 58.8) 58.5 (35.5, 64.5) 0.5577 
LDL cholesterol, mg/dL 105±31.1 111±31.8 0.5708 
Iron, μg/dL 67.0 (59.5, 85.5) 82 (69, 94) 0.4496 
Ferritin, ng/mL 89.3 (63.9, 153) 92.3 (73.6, 194) 0.5432 
Transferrin, mg/dL 233 (211, 260) 212 (162, 220) 0.0327 
PTH, pg/mL 81.4 (57.3, 132) 116 (66, 153) 0.7977 
25OH-vitamin D, ng/mL 22.0 (15.2, 27.2) 23.1 (15.3, 30.4) 0.2398 
sTotal protein, g/dL 7.2 (6.7, 7.6) 7.0 (6.8, 7.3) 0.0434 
sAlbumin, g/dL 4.2±0.3 4.2±0.4 0.7067 
Hemoglobin, g/dL 13.4±1.7 13.7±1.7 0.3694 
Hematocrit, % 40.2±4.6 41.2±4.4 0.4076 
uUrea, g/day 18.5±6.5 17.3±6.3 0.5601 
PCR, g/day 68.4±21.8 65.4±19.6 0.6471 
nPCR, g/kg bw/day 0.8±0.2 0.9±0.2 0.4969 
uSodium, mEq/day 129±50.8 148±50.4 0.2118 
uPhosphate, mg/day 510 (420, 734) 554 (411, 698) 0.8538 
Appetite test score 30 (28, 32) 30.0 (29, 32.8) 0.4353 
MIS 0 (0, 2) 0 (0, 1) 0.2537 
Charlson Comorbidity Index 7 (6, 8) 5.5 (4.0, 7.0) 0.0372 
Barthel Index 103.7±1.3 105±0 0.4479 
Karnowsky score 99.7±0.3 99.5±0.5 0.7973 
Handgrip, kg 28.8±8.1 29.6±8.0 0.6745 
6MWT, m 330±88.9 408±59.7 0.0003 
STS5, s 13.0 (11, 17.5) 11 (8.0, 12) 0.0066 
STS30″ stands, n 11.3±3.0 13.8±2.8 0.0010 
Steps, n 5,288 (3,764, 6,726) 9,199 (7,497, 13,080) 0.0000 
METs 1.2 (1.1, 1.3) 1.6 (1.5, 1.75) 0.0000 
REE, kcal/day 1,322±241 1,244±237 0.2042 
EE, kcal/day 1,805±798 1,927±738 0.6237 
nEE, kcal/day/ibw 26.2±12.2 31.3±7.1 0.2290 
Energy intake, kcal/day 1,702±300 1,907±431 0.0802 
nEnergy intake, kcal/kg ibw 24.5±3.8 28.4±7.4 0.0193 
Sedentary lifestyle (n = 95)Not sedentary lifestyle (n = 20)p value
Age, years 72.0 (67.0, 77.0) 65.5 (51.8, 71.8) 0.0002 
BMI, kg/m2 28.2 (25.9, 30.9) 26.3 (23.8, 28.4) 0.0077 
Waist circumference, cm 103±10.2 96.9±9.4 0.0192 
Hip circumference, cm 105±7.9 101±5.2 0.0151 
Arm circumference, cm 30.2±2.8 28.9±2.6 0.0710 
Triceps skinfold, cm 1.2 (0.9, 1.5) 1.2 (0.73, 1.85) 0.8990 
MAMC, cm 26.1±2.8 24.7±3.1 0.0522 
MAMA, cm2 54.2±13.1 49.1±11.7 0.1190 
Phase angle, ° 4.7 (4.1, 5.4) 5.2 (4.9, 6.1) 0.0051 
BCM, % 46.8±5.9 51.3±4.4 0.0039 
TBW, % 52.9±5.1 55.9±5.0 0.0298 
ECW, % 52.2±5.6 48.0±4.1 0.0037 
ICW, % 47.9±6.0 54.0±4.5 0.0055 
FM, % 30.8±7.0 24.7±6.9 0.0013 
FFM, % 69.2±7.0 75.3±6.9 0.0013 
BCMI, kg/m2 9.2±1.6 10.2±1.3 0.0263 
eGFR, mL/min/1.73 m2 31.4±12.8 30.6±13.2 0.8016 
sSodium, mEq/L 141±2.5 141±2.4 0.7913 
sPotassium, mEq/L 4.7±0.5 4.8±0.6 0.4055 
sCalcium, mg/dL 9.3±0.5 9.4±0.4 0.5603 
sPhosphate, mg/dL 3.3±0.6 3.3±0.8 0.9333 
sBicarbonate, mEq/L 24.5±2.9 23.8±2.6 0.4307 
sGlucose, mg/dL 99.0 (87.0, 114) 87 (82, 102) 0.2650 
HbA1c, % 6.3 (5.9, 7.0) 6.4 (6.2, 7.0) 0.6830 
sUric acid, mg/dL 6.4±1.6 5.5±1.0 0.0258 
sCholesterol, mg/dL 177±35.3 185±29.1 0.4463 
HDL cholesterol, mg/dL 47.5 (39.0, 58.8) 58.5 (35.5, 64.5) 0.5577 
LDL cholesterol, mg/dL 105±31.1 111±31.8 0.5708 
Iron, μg/dL 67.0 (59.5, 85.5) 82 (69, 94) 0.4496 
Ferritin, ng/mL 89.3 (63.9, 153) 92.3 (73.6, 194) 0.5432 
Transferrin, mg/dL 233 (211, 260) 212 (162, 220) 0.0327 
PTH, pg/mL 81.4 (57.3, 132) 116 (66, 153) 0.7977 
25OH-vitamin D, ng/mL 22.0 (15.2, 27.2) 23.1 (15.3, 30.4) 0.2398 
sTotal protein, g/dL 7.2 (6.7, 7.6) 7.0 (6.8, 7.3) 0.0434 
sAlbumin, g/dL 4.2±0.3 4.2±0.4 0.7067 
Hemoglobin, g/dL 13.4±1.7 13.7±1.7 0.3694 
Hematocrit, % 40.2±4.6 41.2±4.4 0.4076 
uUrea, g/day 18.5±6.5 17.3±6.3 0.5601 
PCR, g/day 68.4±21.8 65.4±19.6 0.6471 
nPCR, g/kg bw/day 0.8±0.2 0.9±0.2 0.4969 
uSodium, mEq/day 129±50.8 148±50.4 0.2118 
uPhosphate, mg/day 510 (420, 734) 554 (411, 698) 0.8538 
Appetite test score 30 (28, 32) 30.0 (29, 32.8) 0.4353 
MIS 0 (0, 2) 0 (0, 1) 0.2537 
Charlson Comorbidity Index 7 (6, 8) 5.5 (4.0, 7.0) 0.0372 
Barthel Index 103.7±1.3 105±0 0.4479 
Karnowsky score 99.7±0.3 99.5±0.5 0.7973 
Handgrip, kg 28.8±8.1 29.6±8.0 0.6745 
6MWT, m 330±88.9 408±59.7 0.0003 
STS5, s 13.0 (11, 17.5) 11 (8.0, 12) 0.0066 
STS30″ stands, n 11.3±3.0 13.8±2.8 0.0010 
Steps, n 5,288 (3,764, 6,726) 9,199 (7,497, 13,080) 0.0000 
METs 1.2 (1.1, 1.3) 1.6 (1.5, 1.75) 0.0000 
REE, kcal/day 1,322±241 1,244±237 0.2042 
EE, kcal/day 1,805±798 1,927±738 0.6237 
nEE, kcal/day/ibw 26.2±12.2 31.3±7.1 0.2290 
Energy intake, kcal/day 1,702±300 1,907±431 0.0802 
nEnergy intake, kcal/kg ibw 24.5±3.8 28.4±7.4 0.0193 

MAMC, middle-arm muscle circumference; MAMA, middle-arm muscle area; BCM, body cell mass, TBW, total body water; ECW, extracellular water; ICW, intracellular water; FM, fat mass; FFM, free fat mass; BCMI, body cell mass index; PCR, protein catabolic rate; nPCR, normalized protein catabolic rate; 6MWT, 6-min walking test; STS, sit to stand; MET, metabolic equivalent task; REE, resting energy expenditure; EE, energy expenditure; nEE, normalized energy expenditure; ibw, ideal body weight.

The 82.6% of our patients have a sedentary lifestyle. They were older, had a higher BMI, waist and hip circumferences while the phase angle, BCM, and FFM were significantly lower than that in non-sedentary subjects.

There were no differences in renal function. The sedentary patients had higher blood glucose levels (35% had diabetes compared to 14% of the non-sedentary patients), lower LDL cholesterol levels (probably due to drug therapy), and lower serum albumin levels (Table 2). There were no differences regarding the handgrip test, while performance on the STS30″ was worse in the sedentary than in the non-sedentary patients.

The former had lower estimated protein and salt intakes, probably because they are older than the latter. In any case, the estimated average protein intake of sedentary patients resulted 0.85 g/kg bw/day, which is well in line with the most recent recommendations [29]. The type of diet prescribed was the same in both groups: normal diet in 71% and low protein diet (standard low protein/vegan diet) in 29% of sedentary patients and normal diet in the 72% and low protein diet (standard low protein/vegan diet) in 28% of non-sedentary patients.

Overall, our study shows that CKD patients are mostly overweight/obese with a prevalence of abdominal obesity, while muscle mass and physical performance are reduced compared to the predicted values per age and sex. Our research also shows that older adult patients with CKD tend to have a sedentary lifestyle. Sedentary patients are older than not sedentary patients and this is largely expected since it is well known that physical activity decreases along with age.

Moreover, sedentary CKD patients are different from non-sedentary ones in terms of body composition, physical capacity, and nutrients intake, even when adjusted for age. This is an important consideration in the daily-life management care of CKD patients who are getting older and at risk of both malnutrition and low physical performance and activity.

The assessment of physical activity includes subjective and objective methods. The former are usually questionnaires (including IPAQ), which are easy to administer but have the relevant bias of misreporting due to patient willingness or perception. The latter instead provides more precise information on quantity, i.e., number of steps or meters walked per day, or intensity (METs), using more or less complex devices (including pedometers). In this study, we used the SWA, a device that allows us to obtain quantitative and qualitative details about the physical activity of the recruited patients during their daily lives. We chose this method of physical activity assessment because it is objective, instrumental, and therefore provides more reliable data than those derived by subjective methods such as the IPAQ.

The significant association we found between low levels of daily physical activity and changes in body composition does not imply a cause-and-effect relationship, because of the study design, but it is likely that there are reciprocal influences.

In fact, it is conceivable that sedentary habits may have negative effects on FFM, muscle strength, and exercise capacity and increase fat body mass. Conversely, a reduction in muscle mass and/or an increase in FM may lead to a reduction in physical activity and exercise capacity.

The most relevant question is not which came first but the potential relationship between nutrition and physical performance. They are really two sides of the same coin.

Then, in clinical practice, we can implement physical activity and exercise programs not only to increase functional capacity but also to improve body composition and nutritional status. Conversely, in the presence of inadequate dietary intake, nutritional support tailored on the patient’s habits, clinical parameters, and kidney function is essential to improve body composition and even functional capacity. The combination of nutritional intervention and physical exercise is expected to counteract the vicious cycle that leads to a decline in quality of life and activities of daily living and ultimately to PEW [30, 31].

Very recent data from the 2007 to 2016 National Health and Nutrition Examination Survey showed that CKD patients with a sedentary lifestyle had a higher risk of all-cause and CVD-related mortality. In this case, sedentary lifestyle was defined as a period of inactivity >6 h per day (defined as sedentary time) [32].

Sarcopenia is quite prevalent in CKD patients. It is defined as reduced muscle mass, muscle strength, and physical performance, and it is a strong predictor of increased risk of hospitalization and all-cause mortality [33]. Nutritional therapy alone or in combination with a personalized exercise program may be a useful tool for the prevention or treatment of sarcopenia in CKD and dialysis patients [34]. It is recommended that older people (>65 years) engage in moderate intensity (i.e., of about 3–6 METs) physical activity for at least 150 min per week, or vigorous intensity (i.e., >6 METs) physical activity for at least 75 min per week [35, 36].

In our study, patients who did both moderate or vigorous physical activity were quite rare. The reasons for low physical activity reported by most patients are diverse, ranging from fatigue to lack of time and general laziness, which affects not only patients with CKD but also the general population. The aging process is a determining factor, as shown in this study, but it cannot be a limiting factor [37].

The future holds a population characterized by older people with more comorbidities and disabilities, and this means that we need to introduce neuromuscular rehabilitation programs as soon as possible, integrated with appropriate nutritional therapy, which is essential for effective exercise interventions. Educational programs should be implemented to explain the effects of exercise to encourage inactive CKD patients to start exercising.

Several international working groups are currently addressing the issue of the contribution of physical inactivity to the burden of disease in patients with chronic renal failure [38, 39]. Evidence exists that a rehabilitation program designed as a combination of personalized exercise and nutritional therapy for patients with renal, cardiac, and pulmonary impairments can not only improve exercise capacity and quality of life but also have a positive effect on survival. The new concept of this comprehensive rehabilitation for patients with CKD aims to add life to years and years to life [40].

The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Pisa University Hospital (protocol code: 66006, date of approval: November 6, 2014). Written informed consent was obtained from participants to participate in the study.

The authors declare no conflict of interest.

This research received no external funding.

Conceptualization: C.D., D.G., and A.C.; methodology and validation: C.D. and A.C.; software and writing – original draft preparation: C.D.; formal analysis: E.L. and C.D.; writing – review and editing: A.C., D.G. V.P, N.P. M.R.R., and E.L.; and supervision: A.C. All authors have read and agreed to the published version of the manuscript.

The data generated or analyzed during this study are included in this article. Further inquiries can be directed to the corresponding author (A.C.).

1.
Global Action Plan on physical activity 2018-2030: more active people for a healthier world
.
WHO
;
2018
. Available from: https://apps.who.int/iris/bitstream/handle/10665/272722/9789241514187-eng.pdf (Accessed April 2024).
2.
Physical Activity strategy for the WHO European Region 2016-2025 WHO 2016. Available at Physical activity strategy for the WHO European Region 2016-2025 (Accessed April 2024).
3.
Blair
S
,
Kohl
KR
,
Paffenbarger
R
,
Clark
D
,
Cooper
K
,
Gibbons
L
.
Physical fitness and all-cause mortality: a prospective study of healthy men and women
.
JAMA
.
1989
;
258
:
2388
95
.
4.
Roshanravan
B
,
Robinson-Cohen
C
,
Patel
KV
,
Ayers
E
,
Littman
AJ
,
de Boer
IH
, et al
.
Association between physical performance and all-cause mortality in CKD
.
J Am Soc Nephrol
.
2013
;
24
(
5
):
822
30
.
5.
D’Alessandro
C
,
Giannese
D
,
Panichi
V
,
Cupisti
A
.
Mediterranean dietary pattern adjusted for CKD patients: the MedRen diet
.
Nutrients
.
2023
;
15
(
5
):
1256
.
6.
Bellizzi
V
,
Cupisti
A
,
Locatelli
F
,
Bolasco
P
,
Brunori
G
,
Cancarini
G
, et al
.
Low-protein diets for chronic kidney disease patients: the Italian experience
.
BMC Nephrol
.
2016
;
17
(
1
):
77
.
7.
D’Alessandro
C
,
Piccoli
GB
,
Calella
P
,
Brunori
G
,
Pasticci
F
,
Egidi
MF
, et al
.
“Dietaly”: practical issues for the nutritional management of CKD patients in Italy
.
BMC Nephrol
.
2016
;
17
(
1
):
102
.
8.
Cupisti
A
,
Morelli
E
,
Meola
M
,
Barsotti
M
,
Barsotti
G
.
Vegetarian diet alternated with conventional low-protein diet for patients with chronic renal failure
.
J Ren Nutr
.
2002
;
12
(
1
):
32
7
.
9.
Grundmann
O
,
Yoon
SL
,
Williams
JJ
.
The value of bioelectrical impedance analysis and phase angle in the evaluation of malnutrition and quality of life in cancer patients--a comprehensive review
.
Eur J Clin Nutr
.
2015
;
69
(
12
):
1290
7
.
10.
Małecka-Massalska
T
,
Mlak
R
,
Smolen
A
,
Morshed
K
.
Bioelectrical impedance phase angle and subjective global assessment in detecting malnutrition among newly diagnosed head and neck cancer patients
.
Eur Arch Oto-Rhino-Laryngol
.
2016
;
273
(
5
):
1299
305
.
11.
Sarmento-Dias
M
,
Santos-Araújo
C
,
Poínhos
R
,
Oliveira
B
,
Sousa
M
,
Simões-Silva
L
, et al
.
Phase angle predicts arterial stiffness and vascular calcification in peritoneal dialysis patients
.
Perit Dial Int
.
2017
;
37
(
4
):
451
7
.
12.
Shin
JH
,
Kim
CR
,
Park
KH
,
Hwang
JH
,
Kim
SH
.
Predicting clinical outcomes using phase angle as assessed by bioelectrical impedance analysis in maintenance hemodialysis patients
.
Nutrition
.
2017
;
41
:
7
13
.
13.
Beberashvili
I
,
Azar
A
,
Sinuani
I
,
Shapiro
G
,
Feldman
L
,
Stav
K
, et al
.
Bioimpedance phase angle predicts muscle function, quality of life and clinical outcome in maintenance hemodialysis patients
.
Eur J Clin Nutr
.
2014
;
68
(
6
):
683
9
.
14.
Han
BG
,
Lee
JY
,
Kim
JS
,
Yang
JW
.
Clinical significance of phase angle in non-dialysis CKD stage 5 and peritoneal dialysis patients
.
Nutrients
.
2018
;
10
(
9
):
1331
.
15.
Mafra
D
,
Deleaval
P
,
Teta
D
,
Cleaud
C
,
Perrot
MJ
,
Rognon
S
, et al
.
New measurements of energy expenditure and physical activity in chronic kidney disease
.
J Ren Nutr
.
2009
;
19
(
1
):
16
9
.
16.
Jakicic
JM
,
Marcus
M
,
Gallagher
KI
,
Randall
C
,
Thomas
E
,
Goss
FL
, et al
.
Evaluation of the SenseWear Pro Armband to assess energy expenditure during exercise
.
Med Sci Sports Exerc
.
2004
;
36
(
5
):
897
904
.
17.
Mignault
D
,
St Onge
M
,
Karelis
AD
,
Allison
DB
,
Rabasa-Lhoret
R
.
Evaluation of the portable health wear armband
.
Diabetes Care
.
2005
;
28
(
1
):
225
7
.
18.
St-Onge
M
,
Mignault
D
,
Allison
DB
,
Rabasa-Lhoret
R
.
Evaluation of a portable device to measure daily energy expenditure in free-living adults
.
Am J Clin Nutr
.
2007
;
85
(
3
):
742
9
.
19.
Johannsen
DL
,
Calabro
MA
,
Stewart
J
,
Franke
W
,
Rood
JC
,
Welk
GJ
.
Accuracy of armband monitors for measuring daily energy expenditure in healthy adults
.
Med Sci Sports Exerc
.
2010
;
42
(
11
):
2134
40
.
20.
Copeland
JL
,
Esliger
DW
.
Accelerometer assessment of physical activity in active, healthy older adults
.
J Aging Phys Act
.
2009
;
17
(
1
):
17
30
.
21.
Macfarlane
DJ
,
Chou
KL
,
Cheng
YH
,
Chi
I
.
Validity and normative data for thirty second chair stand test in elderly community-dwelling Hong Kong Chinese
.
Am J Hum Biol
.
2006
;
18
(
3
):
418
21
.
22.
Jones
CJ
,
Rikli
RE
,
Beam
WC
.
A 30-s chair-stand test as a measure of lower body strength in community-residing older adults
.
Res Q Exerc Sport
.
1999
;
70
(
2
):
113
9
.
23.
Mong
Y
,
Teo
TW
,
Ng
SS
.
5-repetition sit-to-stand test in subjects with chronic stroke: reliability and validity
.
Arch Phys Med Rehabil
.
2010
;
91
(
3
):
407
13
.
24.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories
.
ATS statement: guidelines for the six-minute walk test
.
Am J Respir Crit Care Med
.
2002
;
166
(
1
):
111
7
.
25.
Levey
AS
,
Stevens
LA
,
Schmid
CH
,
Zhang
YL
,
Castro
AF
3rd
,
Feldman
HI
, et al
.
A new equation to estimate glomerular filtration rate
.
Ann Intern Med
.
2009
;
150
(
9
):
604
12
.
26.
Maroni
BJ
,
Steinman
TI
,
Mitch
WE
.
A method for estimating nitrogen intake of patients with chronic renal failure
.
Kidney Int
.
1985
;
27
(
1
):
58
65
.
27.
Schlussel
MM
,
dos Anjos
LA
,
de Vasconcellos
MTL
,
Kac
G
.
Reference values of handgrip dynamometry of healthy adults: a population-based study
.
Clin Nutr
.
2008
;
27
(
4
):
601
7
.
28.
Bohannon
RW
.
Reference values for the five-repetition sit-to-stand test: a descriptive meta-analysis of data from elders
.
Percept Mot Skills
.
2006
;
103
(
1
):
215
22
.
29.
Kidney Disease Improving Global Outcomes KDIGO CKD Work Group
.
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
.
Kidney Int
.
2024
;
105
(
4S
):
S117
14
.
30.
Cupisti
A
,
D’Alessandro
C
,
Fumagalli
G
,
Vigo
V
,
Meola
M
,
Cianchi
C
, et al
.
Nutrition and physical activity in CKD patients
.
Kidney Blood Press Res
.
2014
;
39
(
2–3
):
107
13
.
31.
de Geus
M
,
Dam
M
,
Visser
WJ
,
Ipema
KJR
,
de Mik-van Egmond
AME
,
Tieland
M
, et al
.
The impact of combined nutrition and exercise interventions in patients with chronic kidney disease
.
Nutrients
.
2024
;
16
(
3
):
406
.
32.
Chuang
MH
,
Wang
HW
,
Huang
YT
,
Ho
CH
,
Jiang
MY
.
Association of sedentary lifestyle with all-cause and cause-specific mortality in adults with reduced kidney function
.
Kidney
.
2024
;
5
(
1
):
33
43
.
33.
Carrero
JJ
,
Chmielewski
M
,
Axelsson
J
,
Snaedal
S
,
Heimburger
O
,
Barany
P
, et al
.
Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients
.
Clin Nutr
.
2008
;
27
(
4
):
557
64
.
34.
Noce
A
,
Marrone
G
,
Ottaviani
E
,
Guerriero
C
,
Di Daniele
F
,
Pietroboni Zaitseva
A
, et al
.
Uremic sarcopenia and its possible nutritional approach
.
Nutrients
.
2021
;
13
(
1
):
147
.
35.
American Diabetes Association
.
4. Lifestyle management: standards of medical care in diabetes
.
Diabetes Care
.
2018
;
41
(
Suppl 1
):
S38
50
.
37.
Kohzuki
M
.
Paradigm shift in rehabilitation medicine in the era of multimorbidity and multiple disabilities (MMD)
.
Phys Med Rehabil Int
.
2014
;
1
:
4
.
38.
Yamagata
K
,
Hoshino
J
,
Sugiyama
H
,
Hanafusa
N
,
Shibagaki
Y
,
Komatsu
Y
, et al
.
Clinical practice guideline for renal rehabilitation: systematic reviews and recommendations of exercise therapies in patients with kidney diseases
.
Ren Replace Ther
.
2019
;
5
(
1
):
28
.
39.
Williams
AD
,
Fassett
RG
,
Coombes
JS
.
Exercise in CKD: why is it important and how should it be delivered
.
Am J Kidney Dis
.
2014
;
64
(
3
):
329
31
.
40.
Kohzuki
M
.
Renal rehabilitation: present and future perspectives
.
J Clin Med
.
2024
;
13
(
2
):
552
.